According to Pharmaxis latest financial reports the total debt is $1.53M, an decrease of -47.34% to 2021. At the end of 2021 company had $2.90M total debt. This figure represents the debts and financial obligations that Pharmaxis combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2022 | $1.53M | -47.34% |
2021 | $2.90M | -32.14% |
2020 | $4.28M | 5.93% |
2019 | $4.04M | - |